New Zealand could become a mecca for clinical trials as “niche-busting”
cancer drugs replace blockbusters, according to a US research leader.
If
it set up a database of all cancer patients’ medical histories, along
with genetic profiles of their cancers, this country could attract
companies wanting to trial new personalised drugs, University of
Colorado associate professor of medicine and oncology Ross Camidge says.
“People would be beating down the door to work here,” he said, addressing a parliamentary breakfast in Wellington on Wednesday. New Zealand Association of Clinical Research president Kevin Sheehy says our cancer register could potentially link to genetic data and trial participation, provided privacy concerns were met.
http://www.nzdoctor.co.nz/news/2015/june-2015/26/drug-trials---a-way-for-nz-to-get-front-and-centre-of-new-cancer-therapies.aspx
“People would be beating down the door to work here,” he said, addressing a parliamentary breakfast in Wellington on Wednesday. New Zealand Association of Clinical Research president Kevin Sheehy says our cancer register could potentially link to genetic data and trial participation, provided privacy concerns were met.
http://www.nzdoctor.co.nz/news/2015/june-2015/26/drug-trials---a-way-for-nz-to-get-front-and-centre-of-new-cancer-therapies.aspx